Filing Details

Accession Number:
0001628280-22-029866
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-14 16:31:50
Reporting Period:
2022-11-09
Accepted Time:
2022-11-14 16:31:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1938159 Michael Scott Habig #1203-4464 Markham Street
Victoria A1 V8Z 7X8
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-09 5,000 $5.02 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct